Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1186P (RNA, U6 small nuclear 1186, pseudogene) is a noncoding genomic DNA segment derived from the U6 small nuclear RNA gene, which originally encodes an essential RNA for spliceosome function in nuclear pre-mRNA splicing[5]. As a pseudogene, RNU6-1186P is not known to produce a functional transcript or protein, nor is it implicated in any characterized biological processes or diseases. U6 snRNA pseudogenes are abundant in the genome and can sometimes be transcribed, but the vast majority serve as molecular fossils without clear function[5][12]. In some cases, pseudogenes may exert regulatory effects (such as antisense regulation or acting as RNA decoys), but there is no evidence RNU6-1186P participates in such roles[6]. It is not a receptor, enzyme, transporter, or therapeutic target.
None (No mechanisms established, as it is not a therapeutic target.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1186, pseudogene (RNU6-1186P).